Global High-Priority Regulatory Events — February 24, 2026

25-02-2026

25-02-2026

25-02-2026

25-02-2026

25-02-2026

25-02-2026

Waaree Energies Limited (544277) issued a rumour verification clarification under SEBI LODR Regulation 30(11) on February 25, 2026, as disclosed on BSE. No specific details about the news, rumour, or clarification content are provided in the filing summary. This is a routine compliance disclosure with no financial metrics, corporate actions, or operational impacts mentioned.

25-02-2026

BLACKBOXSTOCKS INC. filed an 8-K on 2026-02-25 disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01), with a change in control of the registrant (Item 5.01), unregistered sales of equity securities (Item 3.02), and material modifications to rights of security holders (Item 3.03). Governance changes include departure/election of directors/officers and compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws (Item 5.03), and amendments to the code of ethics (Item 5.05). Additional items cover Regulation FD disclosure (Item 7.01), other events (Item 8.01), and financial statements/exhibits (Item 9.01); no quantitative metrics, deal terms, or parties were disclosed.

25-02-2026

25-02-2026

XWELL, Inc. filed a Form 8-K on February 25, 2026, disclosing multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This multi-item filing signals several corporate governance, financing, and structural changes, but specific details, transaction values, personnel involved, amendment contents, or financial impacts are NOT_DISCLOSED. No quantitative metrics, period-over-period comparisons, or scheduled events are provided in the filing summary.

25-02-2026

ANAVEX LIFE SCIENCES CORP. filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the affected officer, position, appointment or resignation, reasons, or timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or other numerical data are mentioned.

25-02-2026

Battalion Oil Corp filed an 8-K on 2026-02-25 disclosing entry into a material definitive agreement under Item 1.01 and completion of an acquisition or disposition of assets under Item 2.01. Item 9.01 includes financial statements and exhibits, likely pro forma financials related to the transaction. No specific details on deal structure, parties, valuation, synergies, or quantitative metrics are disclosed in the provided filing information.

25-02-2026

LifeStance Health Group, Inc. filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers), alongside results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), other events (Item 8.01), and financial statements and exhibits (Item 9.01). Specific details on the officer change, including key position, appointment or resignation, reasons, or timing, are NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or scheduled events are mentioned in the provided filing information.

25-02-2026

Ashford Hospitality Trust Inc filed an 8-K on 2026-02-25 under Item 5.02 disclosing potential departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers, and under Item 5.03 disclosing amendments to articles of incorporation or bylaws or change in fiscal year. No specific names, positions affected, reasons for changes, timing, or other details are disclosed. This filing provides informational disclosure on leadership and governance matters without quantified financial impacts or directional bias.

25-02-2026

Arcosa, Inc. filed a Form 8-K on February 25, 2026, disclosing entry into a material definitive agreement under Item 1.01, results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No specific details on the agreement, financial metrics, transaction values, or performance comparisons are provided in the filing summary. This multi-item filing indicates potentially significant developments, but lacks quantitative data or directional indicators.

25-02-2026

Kosmos Energy Ltd. filed an 8-K on February 25, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction value, financial impacts, or metrics are disclosed in the provided filing information. No positive, negative, or flat performance metrics are mentioned.

25-02-2026

Shoe Carnival Inc filed an 8-K on 2026-02-25 disclosing results of operations and financial condition (Item 2.02), departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). No specific details on officer identities, positions affected, reasons for change, financial metrics, or performance comparisons are disclosed in the provided information. No quantitative data or directional indicators provided.

25-02-2026

UnitedHealth Group Inc. filed an 8-K on 2026-02-25 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individuals involved, appointment or resignation status, reasons for change, or any financial metrics are disclosed in the provided filing summary. No quantitative data, period-over-period comparisons, or other metrics are mentioned.

• ·AccNo: 0000731766-26-000046
• ·File size: 189 KB
• ·Event date: 2026-02-25
• ·Sector: NOT_DISCLOSED

25-02-2026

AMC Entertainment Holdings, Inc. filed an 8-K on February 25, 2026, under Item 1.01 disclosing entry into a Material Definitive Agreement and Item 9.01 for Financial Statements and Exhibits. No specific details on the agreement, transaction size, financial impacts, or other metrics are provided in the filing summary. This is a multi-item mandatory disclosure with no quantitative data extracted.

25-02-2026

DiamondRock Hospitality Co filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the affected officer's name, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, and timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

25-02-2026

GCT Semiconductor Holding, Inc. filed an 8-K on February 25, 2026, disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 includes financial statements and exhibits. No specific details on the agreement, transaction value, financial impacts, or other metrics are disclosed.

25-02-2026

Incannex Healthcare Inc. filed a Form 8-K on February 25, 2026 (AccNo: 0001213900-26-020127), reporting under Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details provided on the nature of the modifications, amendments, events, or exhibits. No quantitative metrics, financial impacts, positive or negative changes, or period-over-period comparisons are disclosed.

25-02-2026

Allurion Technologies, Inc. filed a Form 8-K on February 25, 2026, disclosing under Item 1.01 entry into a material definitive agreement, Item 3.02 unregistered sales of equity securities, Item 3.03 material modifications to rights of security holders, and Item 9.01 financial statements and exhibits. No quantitative details such as transaction values, share counts, dollar amounts, or financial impacts are disclosed. No positive or negative metrics, period-over-period comparisons, or strategic context are provided in the available information.

• ·Multi-item 8-K filing covering agreement entry, equity sales, and rights changes
• ·AccNo: 0001193125-26-068667
• ·File size: 556 KB

25-02-2026

Reliance Global Group, Inc. filed a Form 8-K on February 25, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 3.02 unregistered sales of equity securities, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. No specific details on the agreement terms, equity sales volume, or disclosures are provided. This is a multi-item mandatory filing with no quantitative impacts or period-over-period comparisons disclosed.

25-02-2026

Intuitive Machines, Inc. filed a Form 8-K on February 25, 2026 (AccNo: 0001193125-26-068729), reporting under Item 1.01 entry into a material definitive agreement, under Item 3.02 unregistered sales of equity securities, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific transaction details, dollar values, share counts, financial metrics, or performance comparisons disclosed in the provided information. No positive or negative metrics are mentioned.

25-02-2026

Totaligent, Inc. filed an 8-K on February 25, 2026, reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 discloses financial statements and exhibits. No specific details, dollar values, financial impacts, or other metrics are provided in the filing summary.

25-02-2026

Capri Holdings Ltd filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). Specific details on the officer involved, position affected, reason for change, or any quantitative impacts are NOT_DISCLOSED.

25-02-2026

Confluent, Inc. filed an 8-K on 2026-02-25 under Item 5.02 disclosing information related to the departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, timing, or any quantitative impacts were provided in the available filing summary. This represents a standard SEC-required disclosure for potential material leadership or governance events.

25-02-2026

Permex Petroleum Corp filed an 8-K on 2026-02-25 disclosing a triggering event that accelerates or increases a direct financial obligation (Item 2.04), an officer change or director departure/election (Item 5.02), other events (Item 8.01), and financial statements/exhibits (Item 9.01). Specific details including the officer's name, title, reason for change, and financial impacts are NOT_DISCLOSED. No quantitative metrics, period-over-period comparisons, or scheduled events are mentioned.

25-02-2026

SOUTHERN CO filed an 8-K on 2026-02-25 reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No details on transaction value, terms, parties, financial impact, or strategic context are disclosed.

25-02-2026

Alkermes plc filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, timing, or any quantitative impacts are NOT_DISCLOSED. No financial metrics, period-over-period comparisons, or other numerical data are provided.

25-02-2026

Frontera Group Inc. filed an 8-K on 2026-02-25 disclosing the completion of an acquisition or disposition of assets under Item 2.01. The filing also addresses departures of directors or certain officers, elections of directors, appointments of certain officers, and compensatory arrangements of certain officers under Item 5.02. No financial terms, parties involved, deal structure, or quantitative metrics are disclosed.

25-02-2026

Nukkleus Inc. filed a Form 8-K on 2026-02-25 disclosing multiple events under Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). No specific details, transaction values, personnel names, share counts, financial metrics, or impacts are disclosed in the provided filing summary. This multi-item filing signals potentially material developments, but lacks quantitative data for assessment.

25-02-2026

Bitcoin Infrastructure Acquisition Corp Ltd filed an 8-K on 2026-02-25 under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits), likely related to a merger/acquisition event. No specific deal structure, parties, valuation, financial metrics, or quantitative data are disclosed in the provided filing summary. No positive, negative, or flat performance metrics are mentioned.

25-02-2026

Sky Century Investment, Inc. filed an 8-K on 2026-02-25 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, timing, or impacts are provided. No quantitative financial metrics, performance comparisons, or other material data are disclosed.

25-02-2026

Valmont Industries Inc filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. Specific details including the officer's name, title, reason for change, and whether it is an appointment or departure are NOT_DISCLOSED.

25-02-2026

AmBase Corp filed an 8-K on 2026-02-25 reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. This is a multi-item mandatory disclosure with no specific details on the agreement's parties, terms, value, or financial impacts provided. No quantitative metrics, comparisons, or scheduled events are disclosed.

25-02-2026

MIDDLEFIELD BANC CORP filed an 8-K on 2026-02-25 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific names, positions affected, reasons for change, timing, or financial details are mentioned. No quantitative metrics, performance comparisons, or other impacts are provided.

25-02-2026

PUBLIC CO MANAGEMENT CORP filed an 8-K on 2026-02-25 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details provided on the nature of the agreement, events, or any financial metrics. All quantitative data, transaction values, impacts, or scheduled events are NOT_DISCLOSED.

25-02-2026

Southwest Gas Holdings, Inc. filed an 8-K on February 25, 2026 (AccNo: 0001193125-26-071537) under Item 5.02 disclosing departure of directors or certain officers; election of directors; appointment of certain officers; or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for change, or quantitative data are disclosed in the provided filing summary. No positive or negative metrics, scheduled events, or financial impacts are mentioned.

25-02-2026

Energy Recovery, Inc. filed an 8-K on February 25, 2026, under Items 2.02 (Results of Operations and Financial Condition), 2.05 (Costs Associated with Exit or Disposal Activities), and 2.06 (Material Impairments), with exhibits under Item 9.01. While results of operations are disclosed, the filing also reveals negative developments including material impairments and costs from exit or disposal activities. Specific financial metrics, impacts, or details are NOT_DISCLOSED.

25-02-2026

NIOCorp Developments Ltd filed a Form 8-K on 2026-02-25 disclosing entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details on the agreement, events, financial metrics, positive or negative impacts, or quantitative data are provided in the filing summary. This is a multi-item filing with no disclosed transaction values, performance metrics, or directional implications.

• ·Multi-item 8-K filing (Items 1.01, 7.01, 8.01, 9.01)
• ·AccNo: 0001539497-26-000783, Size: 821 KB
• ·Sector: not specified

25-02-2026

BiomX Inc. filed an 8-K on 2026-02-25 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as key positions affected, names of individuals, reasons for the change, timing, or any quantitative data are disclosed in the provided filing summary. No positive or negative metrics, board impacts, or other governance details are mentioned.

25-02-2026

Honest Company, Inc. filed an 8-K on February 25, 2026, disclosing results of operations and financial condition under Item 2.02, a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements under Item 5.02, and financial statements and exhibits under Item 9.01. No specific details on the officer change, such as name, title, reason, or timing, are provided. No financial metrics, quantitative data, or performance comparisons are disclosed.

25-02-2026

Hour Loop, Inc. filed an 8-K on 2026-02-25 disclosing officer changes under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics are disclosed.

25-02-2026

Dermata Therapeutics, Inc. filed an 8-K on 2026-02-25 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including names, titles, reasons for changes, timing, or any financial metrics are provided in the available information. No quantitative data, performance comparisons, or further implications are disclosed.

25-02-2026

Marsh & McLennan Companies, Inc. filed an 8-K on February 25, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). No specific details on the key position affected, individuals involved, reasons for the change, or any quantitative impacts are provided in the filing summary. This appears to be an informational disclosure with no additional positive or negative metrics mentioned.

25-02-2026

Alexandria Real Estate Equities, Inc. filed an 8-K on February 25, 2026 (AccNo: 0001104659-26-019662), reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No quantitative details such as transaction value, terms, or financial impacts are provided in the filing summary.

25-02-2026

KRONOS WORLDWIDE INC filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and exhibits under Item 9.01. No specific details on the affected officer's position (e.g., CEO, CFO), name, reason for change, or timing are disclosed. No quantitative financial metrics, performance comparisons, or other material data are mentioned.

25-02-2026

Vyome Holdings, Inc. filed an 8-K on February 25, 2026, disclosing under Item 1.01 entry into a Material Definitive Agreement, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, events, or exhibits are provided in the filing summary. No financial metrics, positive or negative changes, or period-over-period comparisons are disclosed.

25-02-2026

Consolidated Edison Inc filed an 8-K on February 25, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. No specific details, quantitative metrics, positive or negative changes, or financial impacts are disclosed in the provided filing summary. This is a multi-item filing with no period-over-period comparisons or directional indicators available.

25-02-2026

CareDx, Inc. filed an 8-K on February 25, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). Specific details on the officer involved, position affected, appointment or resignation status, reasons, or timing are NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or other numerical data are mentioned.

25-02-2026

Generation Income Properties, Inc. filed a Form 8-K on February 25, 2026 (AccNo: 0001193125-26-071590, Size: 383 KB), reporting under Item 1.01 entry into a material definitive agreement. No details on the core event, transaction value, parties involved, financial impacts, or strategic importance are disclosed in the provided information. This appears to be a single-item mandatory disclosure with no quantitative metrics, positive or negative changes, or period-over-period comparisons mentioned.

25-02-2026

TaskUs, Inc. filed an 8-K on February 25, 2026 (AccNo: 0001829864-26-000005, Size: 566 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also covers results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), other events (Item 8.01), and financial statements and exhibits (Item 9.01). Specific details on the officer involved, position affected, reason for change, financial metrics, or performance comparisons are NOT_DISCLOSED.

25-02-2026

Barnwell Industries Inc filed an 8-K on February 25, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No details on the agreement's terms, parties, value, strategic rationale, or financial impacts are provided in the filing summary. This appears to be a multi-item mandatory disclosure with no quantitative metrics or period-over-period comparisons mentioned.

25-02-2026

ADMA Biologics, Inc. filed an 8-K on February 25, 2026 (AccNo: 0001140361-26-006781), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with results of operations and financial condition under Item 2.02. Item 9.01 references financial statements and exhibits. No specific details on the officer, position, reason for change, financial metrics, or performance comparisons are disclosed.

• ·Filing size: 847 KB
• ·Event Type: Officer Change

25-02-2026

Eagle Bancorp Inc filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on the affected position, individual, reason for change, or timing are disclosed.

25-02-2026

Hamilton Insurance Group, Ltd. filed an 8-K on February 25, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected position, appointment or resignation status, reasons, or any quantitative metrics are disclosed.

25-02-2026

374Water Inc. filed an 8-K on February 25, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Specific details on the affected position, individual involved, reason for change, or timing are NOT_DISCLOSED. No quantitative data, governance impacts, or other metrics are mentioned.

25-02-2026

Avantor, Inc. filed a Form 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. Specific details including the officer's name, title, reason for change, appointment or resignation status, and effective date are NOT_DISCLOSED.

25-02-2026

Ecolab Inc. filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or quantitative data are disclosed in the provided information.

• ·Filing Accession Number: 0001104659-26-019742
• ·Filing size: 190 KB
• ·Event date: 2026-02-25

25-02-2026

LSI Industries Inc filed a Form 8-K on February 25, 2026 (AccNo: 0001437749-26-005618, Size: 9 MB), reporting under Item 1.01 entry into a material definitive agreement, Item 7.01 Regulation FD disclosure, Item 8.01 other events, and Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the agreement, disclosures, events, or exhibits provided. No quantitative financial metrics, transaction values, or performance comparisons are disclosed.

25-02-2026

XPEL, Inc. filed an 8-K on February 25, 2026, reporting under Item 3.03 material modifications to rights of security holders, under Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. No specific details, financial metrics, positive or negative changes, or quantitative impacts are disclosed in the provided filing summary. This is a multi-item informational filing on governance matters.

25-02-2026

Spring Valley Acquisition Corp. IV filed an 8-K on February 25, 2026, under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits) related to a merger/acquisition event. No specific details on deal structure, parties involved, valuation, financial terms, or quantitative metrics are disclosed in the filing summary. Sector information is not specified.

25-02-2026

DIEBOLD NIXDORF, Inc. filed a Form 8-K on 2026-02-25 under Item 5.02 disclosing a departure of directors or certain officers; election of directors; appointment of certain officers; or compensatory arrangements of certain officers. No specific names, titles, reasons for the change, effective dates, internal/external status, or quantitative details such as compensation amounts were disclosed in the provided filing information. No financial metrics, performance comparisons, or other material impacts were mentioned.

25-02-2026

OGE Energy Corp. filed an 8-K on February 25, 2026 (AccNo: 0001193125-26-071800), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected position, individual involved, reason for change, appointment or resignation status, timing, or any compensatory arrangements are disclosed. No quantitative metrics, financial impacts, or governance implications are provided.

25-02-2026

Starfighters Space, Inc. filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing were disclosed.

25-02-2026

Bimergen Energy Corp filed an 8-K on February 25, 2026 (AccNo: 0001493152-26-008049), reporting under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. No specific details, transaction values, financial metrics, period-over-period comparisons, or quantitative impacts are disclosed in the provided filing summary. No positive or negative performance metrics are mentioned.

25-02-2026

Fermi Inc. filed an 8-K on 2026-02-25 reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No transaction details, dollar values, strategic impacts, or financial metrics are disclosed.

25-02-2026

Redwire Corp filed a Form 8-K on 2026-02-25 disclosing entry into a material definitive agreement (Item 1.01), termination of a material definitive agreement (Item 1.02), results of operations and financial condition (Item 2.02), and creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), with exhibits under Item 9.01. This multi-item filing indicates potential restructuring or refinancing activities alongside financial updates, but specific transaction details, dollar values, and performance metrics are NOT_DISCLOSED. No period-over-period comparisons, positive or negative metrics, or balanced performance data are provided.

25-02-2026

Bit Digital, Inc. filed an 8-K on 2026-02-25 (AccNo: 0001213900-26-020401, Size: 264 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on the affected officer, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, or timing are provided. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

• ·AccNo: 0001213900-26-020401
• ·Event date: February 25, 2026
• ·Sector: NOT_DISCLOSED

25-02-2026

Bath & Body Works, Inc. filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the affected position, individual names, reasons, or timing are disclosed.

25-02-2026

Neuronetics, Inc. filed a Form 8-K on 2026-02-25 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names, titles, reasons for change, effective dates, or quantitative compensation data are provided in the filing summary. This represents a standard SEC-required disclosure for material leadership events.

25-02-2026

PENTAIR plc filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02, covering potential departures of directors or certain officers, elections or appointments of directors or officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals involved, reasons for change, or any quantitative metrics are disclosed.

• ·AccNo: 0000077360-26-000009
• ·Filing size: 197 KB
• ·Sector: not specified

25-02-2026

Crown Castle Inc. filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position, appointment or resignation status, reasons, timing, or any quantitative metrics are disclosed in the provided filing information.

25-02-2026

Repay Holdings Corp filed an 8-K on February 25, 2026 (AccNo: 0001193125-26-071873), disclosing information under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Specific details on the key position affected, individuals involved, nature of the change (appointment or resignation), reasons, or any quantitative data such as compensation amounts are NOT_DISCLOSED. No other financial metrics, board outcomes, or scheduled events are mentioned.

25-02-2026

HCA Healthcare, Inc. filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on the officer, position, reason, or any quantitative metrics are disclosed.

25-02-2026

Darling Ingredients Inc. filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. Specific details including officer names, positions, reasons for change, or any quantitative impacts are NOT_DISCLOSED.

25-02-2026

Upland Software, Inc. filed an 8-K on February 25, 2026, reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer's position, name, appointment or resignation status, reasons for the change, or any financial metrics are disclosed in the provided filing summary. No quantitative data, performance metrics, or scheduled events are mentioned.

25-02-2026

NeoVolta Inc. filed an 8-K on February 25, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also references Item 9.01 (Financial Statements and Exhibits). No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics are disclosed.

25-02-2026

Braemar Hotels & Resorts Inc. filed an 8-K on February 25, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or any quantitative data are disclosed in the provided filing summary.

25-02-2026

Motorsport Games Inc. filed a Form 8-K on February 25, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No specific details on the agreement terms, transaction value, financial impact, or other metrics are provided.

25-02-2026

Tevogen Bio Holdings Inc. filed an 8-K on February 25, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. The filing also includes Item 5.07 on submission of matters to a vote of security holders and Item 9.01 on financial statements and exhibits. No specific details on positions affected, names, reasons for changes, vote outcomes, or exhibits are disclosed.

25-02-2026

urban-gro, Inc. filed an 8-K on February 25, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 3.02 unregistered sales of equity securities, with Item 9.01 providing financial statements and exhibits. This is a multi-item mandatory disclosure with no specific details on transaction terms, values, or impacts disclosed. No quantitative financial metrics, positive or negative changes, or period-over-period comparisons are mentioned.

25-02-2026

Premier Air Charter Holdings Inc. filed an 8-K on 2026-02-25 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or quantitative data are disclosed.

25-02-2026

Soulpower Acquisition Corp. filed an 8-K on 2026-02-25 disclosing entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03. Item 9.01 provides financial statements and exhibits. No quantitative metrics, deal terms, parties, or performance comparisons disclosed.

25-02-2026

YIJIA GROUP CORP. filed an 8-K on 2026-02-25 under Item 5.02 disclosing an officer change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are provided. No quantitative data, financial metrics, or other implications are mentioned.

25-02-2026

Manhattan Bridge Capital, Inc. filed an 8-K on February 25, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement's terms, parties, value, or financial impacts are disclosed. No quantitative metrics, positive or negative changes, or performance comparisons are provided.

• ·Filing Accession Number: 0001493152-26-008061
• ·Filing size: 321 KB
• ·Sector: NOT_DISCLOSED

25-02-2026

MARA Holdings, Inc. filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons, or terms are disclosed.

25-02-2026

Vishay Intertechnology Inc. filed an 8-K on February 25, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. Specific details on the affected officer, position, appointment or resignation status, reasons, and timing are NOT_DISCLOSED.

25-02-2026

Avalon GloboCare Corp. filed a Form 8-K on February 25, 2026, disclosing multiple events under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 3.02 (Unregistered Sales of Equity Securities), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), and Item 9.01 (Financial Statements and Exhibits). No specific transaction values, financial impacts, named parties, or quantitative details were provided in the filing summary. This multi-item filing signals potential strategic, financial, and governance changes, but lacks disclosure on directionality or magnitude.

25-02-2026

Solstice Advanced Materials Inc. filed an 8-K on 2026-02-25 reporting under Item 5.02 regarding departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 discloses financial statements and exhibits. No specific details on individuals, reasons, effective dates, or financial terms are provided in the filing summary.

25-02-2026

Catalyst Crew Technologies Corp. filed an 8-K on 2026-02-25 disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01). The transaction triggered changes in control of the registrant (Item 5.01), departure or election of directors and officers with compensatory arrangements (Item 5.02), a change in shell company status (Item 5.06), and unregistered sales of equity securities (Item 3.02). No financial terms, parties involved, valuations, or quantitative metrics were disclosed.

25-02-2026

Sarepta Therapeutics, Inc. filed an 8-K on February 25, 2026 (AccNo: 0001193125-26-072064) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for changes, timing, or quantitative impacts are disclosed. No positive or negative metrics are mentioned.

25-02-2026

Armada Acquisition Corp. III filed an 8-K on 2026-02-25 under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits) in connection with a merger/acquisition event. No specific details on parties, deal structure, valuation, financial metrics, or performance comparisons are disclosed in the provided filing summary. All quantitative and qualitative transaction information remains NOT_DISCLOSED.

25-02-2026

Flotek Industries Inc. filed an 8-K on February 25, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals, reasons for change, timing, or any quantitative financial metrics were disclosed.

25-02-2026

Ideal Power Inc. filed a Form 8-K on February 25, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 3.02 unregistered sales of equity securities, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. This is a multi-item mandatory and voluntary disclosure with no specific transaction details, dollar values, share counts, financial impacts, or strategic context provided in the filing summary. No positive or negative metrics, period-over-period changes, or guidance revisions are disclosed.

25-02-2026

DIAMOND HILL INVESTMENT GROUP INC filed an 8-K on 2026-02-25 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals involved, reasons for change, or any quantitative metrics are disclosed.